|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 38/31 |
| (11) | Number of the document | 1968549 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06841059.6 |
| Date of filing the European patent application | 2006-12-20 | |
| (97) | Date of publication of the European application | 2008-09-17 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2006/012313 |
| Date | 2006-12-20 |
| (87) | Number | WO 2007/071395 |
| Date | 2007-06-28 |
| (30) | Number | Date | Country code |
| 0526247 | 2005-12-22 | GB | |
| 06119086 | 2006-08-17 | EP |
| (72) |
PETERSEN, Holger, DE
AHLHEIM, Markus, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |